Pertussis (Whooping Cough)

2

Review clinical trials related to Pertussis (Whooping Cough). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)

the safety and tolerability of different dosages of adsorbed acellular pertussis (two-component) diphtheria-tetanus combined vaccine

Participants needed: 96
Trial details
Phase: Phase 1Age: 10+Biological sex: AllType: InterventionalSponsor: Changchun BCHT Biotechnology Co.Updated: Mar 25, 2026
Eligibility criteria

People aged 10 years or older; [+5]

Axillary body temperature >37.0°C on the day of enrollment of trial participants... [+15]

Status: Recruiting

Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis

The overall goal of this study is to establish a PRN-deficient pertussis Controlled Human Infection Model (CHIM) that represents currently circulating isolates, in the context of a North American exposure (vaccination and infection) pedigree.

Participants needed: 60
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: Dalhousie UniversityUpdated: Dec 4, 2025Locations: 1
Eligibility criteria

Age 18-50 years, inclusive. [+16]

Underlying chronic medical condition requiring ongoing follow-up and monitoring... [+26]